Results 21 to 30 of about 88,519 (382)

Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral arterial disease, either peripheral arterial occlusive disease or thromboangiitis obliterans ...
Annie M Bérard   +21 more
doaj   +1 more source

Sex disparities in peripheral arterial occlusive disease

open access: yesAngiologia e Cirurgia Vascular, 2023
INTRODUCTION: Recently published studies on peripheral arterial occlusive disease (PAOD) have revealed marked sex disparities in patient selection and treatment outcomes.
Leonor Baldaia   +7 more
doaj   +1 more source

Low mean platelet volume is associated with critical limb ischemia in peripheral arterial occlusive disease. [PDF]

open access: yesSci Rep, 2018
Mean platelet volume (MPV) was recently published as a possible marker of coronary artery disease in patients at high risk for major adverse cardiac events. Because platelets play an important role in atherosclerosis, we examined the relationship between
Rief P   +7 more
europepmc   +2 more sources

Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia

open access: yesFrontiers in Cardiovascular Medicine, 2022
Arterial occlusive disease is the narrowing of the arteries via atherosclerotic plaque buildup. The major risk factors for arterial occlusive disease are age, high levels of cholesterol and triglycerides, diabetes, high blood pressure, and smoking ...
Diane Macabrey   +7 more
doaj   +1 more source

Hyperbaric Oxygen Therapy Enhanced Circulating Levels of Endothelial Progenitor Cells and Angiogenesis Biomarkers, Blood Flow, in Ischemic Areas in Patients with Peripheral Arterial Occlusive Disease. [PDF]

open access: yesJ Clin Med, 2018
Background: This study tested the hypothesis that hyperbaric oxygen (HBO) therapy enhanced the circulating levels of endothelial progenitor cells (EPCs), soluble angiogenesis factors, and blood flow in ischemic areas in patients with peripheral arterial ...
Lin PY   +9 more
europepmc   +2 more sources

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial [PDF]

open access: yes, 2019
Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage.
Al-Shahi Salman, Rustam   +16 more
core   +1 more source

Prevalência da doença arterial obstrutiva periférica em doentes com insuficiência renal crônica Prevalence of peripheral occlusive arterial disease in patients with chronic renal failure

open access: yesJornal Vascular Brasileiro, 2009
Contexto: A doença arterial obstrutiva periférica tem sido reconhecida como um sensível marcador de aterosclerose sistêmica e preditora de eventos cardiovasculares.
José Aderval Aragão   +5 more
doaj   +1 more source

Long-term outcomes of omniflow II biosynthetic vascular graft in lower extremity arterial revascularization [PDF]

open access: yes, 2018
Background: This study aims to evaluate the patency rates and long-term outcomes of femoro-popliteal bypass procedures with Omniflow II biosynthetic vascular grafts in patients with occlusive vascular disease.
Göncü, M.T.   +4 more
core   +1 more source

Barriers and enablers to walking in individuals with intermittent claudication: a systematic review to conceptualize a relevant and patient-centered program [PDF]

open access: yes, 2018
Background: Walking limitation in patients with peripheral arterial disease (PAD) and intermittent claudication (IC) contributes to poorer disease outcomes.
Abaraogu, Ukachukwu   +7 more
core   +5 more sources

Home - About - Disclaimer - Privacy